Osler Diagnostics
Lab-quality diagnostics for anyone, anywhere, at any time.
Lab-quality diagnostics for anyone, anywhere, at any time.
Osler Diagnostics: Osler Diagnostics, a UK-based company founded in 2017, is focused on providing lab-quality diagnostics to individuals globally. Their flagship product, the Osler Origin, is a portable lab that offers a wide range of diagnostic tests, aiming to make healthcare accessible to anyone, anywhere, at any time. The company emerged from the University of Oxford, benefiting from decades of research and expertise. Their last Series C investment of $85.00M was secured on November 7th, 2022, with funding from Lansdowne Partners, M&G Investments, Oxford Science Enterprises, and Braavos Investment Advisers. Osler operates in the Health Care and Life Sciences industries, with its headquarters located in Oxford, United Kingdom. The company's mission to empower individuals to take control of their health aligns with the growing demand for accessible and innovative healthcare solutions.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series C | $85.00M | 4 |
|
07 Nov 2022 |
| Series B | £35.00M | - | 20 Nov 2020 | |
| Series A | £30.00M | - | 01 Jan 2019 | |
| Seed Round | £3.50M | - | 01 Aug 2017 | |
| Seed Round | £2.00M | - | 25 Jul 2016 |
No recent news or press coverage available for Osler Diagnostics.
We care about your data, and we'd love to use cookies make your experience better.
